Literature DB >> 12875924

Inactivation of Ebola virus with a surfactant nanoemulsion.

A A Chepurnov1, L F Bakulina, A A Dadaeva, E N Ustinova, T S Chepurnova, J R Baker.   

Abstract

Hemorrhagic fever caused by Ebola virus (EBO) is a highly contagious infection. This necessitates that the contaminated instruments, clothes, and hospital premises must be completely disinfected. Nanoemulsions are a new form of disinfectant composed of detergents and vegetable oil suspended in water. The antiviral activity of nanoemulsion ATB has been investigated against EBO. The nanoemulsion was tested against two preparations of EBO (strain Zaire) obtained from Vero cell culture fluid (EBO-zc) and from blood of infected monkeys (EBO-zb). The nanoemulsion ATB was virucidal against both preparations of EBO, inactivating the purified virus within 20 min even when diluted 1:100 with the growth medium. Inactivation of the virus in tissue preparations was also complete, but required 1:10 dilutions with media or higher. After treatment with ATB (10 and 1% concentrations), no EBO was apparent even after two passages in Vero cell culture. These data indicate that the nanoemulsion is an effective disinfectant for EBO. Because of the excellent biocompatibility of nanoemulsions, studies are planned to determine whether the nanoemulsion-killed virus is suitable for developing a vaccine against EBO.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875924     DOI: 10.1016/s0001-706x(03)00120-7

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  21 in total

1.  Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type.

Authors:  Sophie J Smither; Simon A Weller; Amanda Phelps; Lin Eastaugh; Sarah Ngugi; Lyn M O'Brien; Jackie Steward; Steve G Lonsdale; Mark S Lever
Journal:  J Clin Microbiol       Date:  2015-07-15       Impact factor: 5.948

Review 2.  The role of nanotechnology in the treatment of viral infections.

Authors:  Lavanya Singh; Hendrik G Kruger; Glenn E M Maguire; Thavendran Govender; Raveen Parboosing
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

3.  Antimicrobial activity of nanoemulsion on cariogenic Streptococcus mutans.

Authors:  Ramalingam Karthikeyan; Bennett T Amaechi; H Ralph Rawls; Valerie A Lee
Journal:  Arch Oral Biol       Date:  2010-11-26       Impact factor: 2.633

4.  Anti-cariogenic effect of a cetylpyridinium chloride-containing nanoemulsion.

Authors:  Valerie A Lee; Ramalingam Karthikeyan; H Ralph Rawls; Bennett T Amaechi
Journal:  J Dent       Date:  2010-06-17       Impact factor: 4.379

5.  Dynamics of the interfacial film in bicontinuous microemulsions based on a partly ionic surfactant mixture: A neutron spin-echo study.

Authors:  S Wellert; H-J Altmann; A Richardt; A Lapp; P Falus; B Farago; T Hellweg
Journal:  Eur Phys J E Soft Matter       Date:  2010-11       Impact factor: 1.890

6.  In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.

Authors:  John J LiPuma; Sivaprakash Rathinavelu; Bridget K Foster; Jordan C Keoleian; Paul E Makidon; Linda M Kalikin; James R Baker
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

7.  Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests.

Authors:  Maiken Worsøe Rosenstierne; Helen Karlberg; Karoline Bragstad; Gunnel Lindegren; Malin Lundahl Stoltz; Cristiano Salata; Anne-Marte Bakken Kran; Susanne Gjeruldsen Dudman; Ali Mirazimi; Anders Fomsgaard
Journal:  J Clin Microbiol       Date:  2016-07-27       Impact factor: 5.948

8.  A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease.

Authors:  Dennis M Lindell; Susan B Morris; Maria P White; Lara E Kallal; Phillip K Lundy; Tarek Hamouda; James R Baker; Nicholas W Lukacs
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

Review 9.  Surfactants - Compounds for inactivation of SARS-CoV-2 and other enveloped viruses.

Authors:  Miriam Simon; Michael Veit; Klaus Osterrieder; Michael Gradzielski
Journal:  Curr Opin Colloid Interface Sci       Date:  2021-06-12       Impact factor: 6.448

10.  Validation of Inactivation Methods for Arenaviruses.

Authors:  Silke Olschewski; Anke Thielebein; Chris Hoffmann; Olivia Blake; Jonas Müller; Sabrina Bockholt; Elisa Pallasch; Julia Hinzmann; Stephanie Wurr; Neele Neddersen; Toni Rieger; Stephan Günther; Lisa Oestereich
Journal:  Viruses       Date:  2021-05-24       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.